PARIS--(BUSINESS WIRE)--With the support of Roche, AstraZeneca and Nerviano Medical Sciences, The WIN Consortium would like to invite the scientific community, pharmaceutical industry and regulators to join the 3rd WIN Symposium, endorsed by ASCO, EORTC, ESMO, INCA and OECI, on 6-8 July 2011 in Paris to hear more about the challenging topic of addressing efficacy of cancer therapeutics and the utility of diagnostics in the era of personalized medicine.